Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia” or the “Company”) is pleased to provide its unaudited financial results for the three- and nine-month periods ended December 31, 2022. These filings and...
Read more
Our plan is to build out a global network of laboratory and regulatory compliance businesses. Most of this expansion is anticipated to take place through acquisitions as we operate in a target-rich industry. Currently we serve consumer goods...
Read more
Toronto, Ontario–(Newsfile Corp. – August 11, 2022) – Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia”) is pleased to announce that its partially owned subsidiary, Britannia Mining Solutions Inc...
Read more
Toronto, Ontario–(Newsfile Corp. – August 2, 2022) – Britannia Life Sciences Inc. (CSE: BLAB) (“Britannia” or the “Company”) is pleased to provide its financial results for the three- and twelve-month...
Read more
Toronto, Ontario–(Newsfile Corp. – May 16, 2022) – Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia”) is pleased to announce that its partially owned subsidiary, Britannia Mining Solutions Inc...
Read more
Get in touch with our team of professionals and let’s start a conversation.